Skip Navigation

European Heart Journal 1987 8(12):1295-1304;
Copyright © 1987 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by TIMMIS, A. D.
Right arrow Articles by GOSLING, R. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by TIMMIS, A. D.
Right arrow Articles by GOSLING, R. G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1987 The European Society of Cardiology

Captopril versus placebo in congestive heart failure: effects on oxygen delivery to exercising skeletal muscle

A. D. TIMMIS, L. M. R. BOJANOWSKI, Y. C. NAJM, D. J. NELSON and R. G. GOSLING

Departments of Cardiology and Radiological Science, Guy's Hospital London, U.K.

Received 29 April 1987; revised 16 June 1987; .

Adam D. Timmis, Department of Cardiology, Guy's Hospital, St Thomas' Street, London SE1 9RT, U.K.

The effects of captopril versus placebo on oxygen consumption in the exercising leg have been examined Doppler measurements of femoral flow and arteriovenous oxygen difference. Twenty patients with heart failure were randomized to captopril 25 mg (N =10) or placebo (N =10). Maximal supine exercise of one was performed before treatment and again 1 h and 4 h afterwards. Systemic haemodynamic variables were unaffected by placebo, but captopril increased stroke index at peak exercise from 26±3 to 34±3 ml beat-1 m-2 and reduced pulmonary artery wedge pressure from 26±3 to 16±3 mmHg (P<0.05). Despite captopril-induced improvement in left ventricular function, exercise duration did not increase significantly peak values for femoral flow (1059±178 to 938±134 ml min -1, P = NS), and oxygen consumption (134±26 to 111±18 ml min-1, P = NS) in the exercising leg were unaffected. Cutaneous flow, as reflected skin temperature (27.5±0.4 to 27.6±0.4°C, P = NS), was also unaffected. In the patients randomized captopril, the acute improvement in left ventricular function was abbreviated and, after 4 h, all variables had returned towards baseline. Moreover, when the invasive studies were repeated after four weeks chronic treatment responsiveness to converting enzyme inhibition had attenuated and there were no detectable differences between the captopril and placebo groups.These data have demonstrated an acute captopril-induced improvement in left ventricular function patients with congestive heart failure. Nevertheless the beneficial acute response was abbreviated predicting the development of early tolerance. Oxygen delivery to the exercising leg showed no tendency to increase acutely when left ventricular function was significantly improved, or chronically when systemic responsiveness had attenuated. Thus irrespective of its effects on left ventricular function, captopril does not increase nutritive flow to exercising skeletal muscle in congestive heart failure.

Key Words: Captopril • congestive heart failure • exercise physiology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.